Because in the long run, how you feel and how you function matters far more than the number on the scale
Orandi, MD, PhD , associate professor of surgery and medicine at NYU Langone Health, about the studys implications and how clinicians may use GLP-1s to mitigate kidney disease and manage transplant outcomes
Most clinical trial participants reported substantial appetite reduction by week 23 of treatment, making eating less feel automatic rather than forced
Future GLP-1 Approvals: The pipeline is robust
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic
Studies using this approach report improvements in ovulation frequency, menstrual regularity, and some metabolic markers, though reviewers consistently note variability in study quality and outcomes.1 2 31 Gestational diabetes research Preventive trials in pregnancy typically use 2,0004,000mg of MI per day , often started in the first trimester